Introducing the Ultimate Market Maverick: 90% Annual Income and 67% Accurate Forecasts with Our New Robot!
This AI Robot is built exclusively for day traders who embrace the art of manual trading and prioritize independent signal selection. With a track record of consistent trading predictions, it empowers traders to make informed choices that align with their individual preferences.
Day Trader, Popular Stocks: Price Action Trading Strategy (TA&FA)
This specialized robot centers its focus on identifying potent short-term price impulses, aiming for swift and efficient profit extraction. With an average trade duration of one day, it enables effective capital utilization and prevents prolonged entanglements in trades.
The algorithm operates on a distinct, intricate approach that identifies potent price impulses across varying market conditions, considering volatility and historical price patterns. Upon pinpointing the situation with the highest probability of sustained price movement, the analysis shifts to the next phase: identifying the ideal entry point utilizing a proprietary set of indicators that evaluate both medium-term and short-term trends.
After opening a trade, two different approaches are used for long and short positions. For long positions, a fixed take profit of 3.25% is established, coupled with a short-term trailing stop. Conversely, short positions adhere to a fixed take profit of 2.5% and a short-term trailing stop.
In our trading endeavors, we opt for the most liquid and actively traded stocks within the dynamic US stock market. This judicious selection streamlines trade execution at desired entry points, alleviating concerns about spreads and liquidity. Additionally, our decision-making is informed by fundamental indicators, steering us clear of shares associated with subpar business quality, and consequently, minimizing exposure to potential risks like bankruptcy or delisting.
Click to view full description and closed trades for free!
Contributor
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
HIVE in downward trend: price expected to drop as it breaks its higher Bollinger Band on August 20, 2026
HIVE broke above its upper Bollinger Band on August 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 48 similar instances where the stock broke above the upper band. In of the 48 cases the stock fell afterwards. This puts the odds of success at .
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for HIVE entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HIVE's RSI Indicator exited the oversold zone, of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where HIVE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on August 20, 2026. You may want to consider a long position or call options on HIVE as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for HIVE just turned positive on August 12, 2026. Looking at past instances where HIVE's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where HIVE advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HIVE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.966) is normal, around the industry mean (4.401). P/E Ratio (9.174) is within average values for comparable stocks, (21.328). HIVE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.691). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. P/S Ratio (2.254) is also within normal values, averaging (17.980).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of cloud networking and enterprise Wi-Fi solution
Industry InvestmentBanksBrokers
Advertisement